Ahmad Ghasemi
Research Subjects
Ahmad Ghasemi has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Jafar Saeidi
Department of Physiology, School of Basic Science, Neyshabur Branch Islamic Azad University Neyshabur Iran
7 shared publicationsMahnaz Mohtashami
Department of Biology, School of Basic Science Neyshabur Branch, Islamic Azad University Neyshabur Iran
6 shared publicationsFatemeh Forooghi Nia
Department of Microbiolgy, College of Science, Agricultuer and Modern Technology, Shiraz Branch Islamic Azad University Shiraz Iran
3 shared publications- Mahnaz Mohtashami
Department of Microbiology, School of Basic Science, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran
3 shared publications Mohsen Azimi-Nezhad
Department of Basic Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran
3 shared publicationsMohsen Azimi‐Nezhad
Healthy Ageing Research Centre Neyshabur University of Medical Sciences Neyshabur Iran
2 shared publications
Latest Publications
- Open Access
- 27 April 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (8)
Preventive Effects of Vanillic Acid Against Lung Inflammation and Oxidative Stress Induced by Dust Particles in Wistar Rats
To evaluate dose‐dependent cytotoxicity effects of indoor dust particles (DPs) collected from Neyshabur, Iran, in vitro on A545 cells and in vivo on lungs of healthy male Wistar rats, as well as the antioxidant effects of vanillic acid (VA) against DP inhalation. Heavy metal levels in DPs collected from high‐traffic (HT), medium‐traffic, low‐traffic or rural (LT) zones were measured, and their cytotoxicity effects were evaluated by MTT assay. In vivo evaluations were conducted after rats were exposed to DPs collected from HT or LT in the presence or absence of VA. Exposure to DPs increased the activity of serum superoxide dismutase; the serum level of malondialdehyde; and mRNA expression of TNFα, IL6, CXCL15 and CYP1A1 in the lung homogenate groups receiving HT and LT compared to the control group. DP effects in the groups receiving HT were higher than those of LT. Concomitant VA intake attenuated the adverse effects mediated by DPs in the HT and LT groups. DPs had adverse effects on the lungs of healthy rats, probably because of the accumulated oxidative stress agents. VA could ameliorate the effects of DPs and may be considered as a protective substance against the undesirable effects of DPs.
- 27 April 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (8)
Open AccessPreventive Effects of Vanillic Acid Against Lung Inflammation and Oxidative Stress Induced by Dust Particles in Wistar Rats
To evaluate dose‐dependent cytotoxicity effects of indoor dust particles (DPs) collected from Neyshabur, Iran, in vitro on A545 cells and in vivo on lungs of healthy male Wistar rats, as well as the antioxidant effects of vanillic acid (VA) against DP inhalation. Heavy metal levels in DPs collected from high‐traffic (HT), medium‐traffic, low‐traffic or rural (LT) zones were measured, and their cytotoxicity effects were evaluated by MTT assay. In vivo evaluations were conducted after rats were exposed to DPs collected from HT or LT in the presence or absence of VA. Exposure to DPs increased the activity of serum superoxide dismutase; the serum level of malondialdehyde; and mRNA expression of TNFα, IL6, CXCL15 and CYP1A1 in the lung homogenate groups receiving HT and LT compared to the control group. DP effects in the groups receiving HT were higher than those of LT. Concomitant VA intake attenuated the adverse effects mediated by DPs in the HT and LT groups. DPs had adverse effects on the lungs of healthy rats, probably because of the accumulated oxidative stress agents. VA could ameliorate the effects of DPs and may be considered as a protective substance against the undesirable effects of DPs.
- 20 July 2023
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 70 (6) , 1941-1953
Inhibitory activity of Limosilactobacillus reuteri isolated from camel milk against Helicobacter pylori effects in human gastric epithelial cells
This study aimed to evaluate anti‐Helicobacter pylori effects of Limosilactobacillus reuteri 2892 (L. reuteri 2892) isolated from camel milk in GC cell lines (AGS and MKN). From 15 camel milk samples, 132 microbial strains were isolated. Based on microbial and biochemical analysis, 11 potential probiotic candidates were selected. The potential probiotic candidates were assayed for anti‐H. pylori activity, and the strain with the highest anti‐H. pylori activity was identified genotypically. Based on 16S rDNA sequencing, the selected strain with the best activity against H. pylori (inhibition zone = 15.5 ± 0.8) belonged to the Lactobacillus reuteri strain 2892. Cell treatment with H. pylori HC‐113 inhibits gene expression of Claudin‐4, ZO‐1, MUC5AC, and MUC2 in gastric cells, which are attenuated by L. reuteri 2892. The simulative effects of H. pylori HC‐113 on the cell migration and invasion of gastric cells were lost when cells were cotreated with L. reuteri 2892. Cell treatment with H. pylori HC‐113 promoted cell death, whereas cotreatment with L. reuteri 2892 markedly decreased necrotic and late apoptotic cells. The present study demonstrates that L. reuteri 2892 has potent anti‐H. pylori effects and thus can be considered as an alternative protective agent against inflammatory effects of H. pylori in gastric cells.
- 20 July 2023
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 70 (6) , 1941-1953
Inhibitory activity of Limosilactobacillus reuteri isolated from camel milk against Helicobacter pylori effects in human gastric epithelial cells
This study aimed to evaluate anti‐Helicobacter pylori effects of Limosilactobacillus reuteri 2892 (L. reuteri 2892) isolated from camel milk in GC cell lines (AGS and MKN). From 15 camel milk samples, 132 microbial strains were isolated. Based on microbial and biochemical analysis, 11 potential probiotic candidates were selected. The potential probiotic candidates were assayed for anti‐H. pylori activity, and the strain with the highest anti‐H. pylori activity was identified genotypically. Based on 16S rDNA sequencing, the selected strain with the best activity against H. pylori (inhibition zone = 15.5 ± 0.8) belonged to the Lactobacillus reuteri strain 2892. Cell treatment with H. pylori HC‐113 inhibits gene expression of Claudin‐4, ZO‐1, MUC5AC, and MUC2 in gastric cells, which are attenuated by L. reuteri 2892. The simulative effects of H. pylori HC‐113 on the cell migration and invasion of gastric cells were lost when cells were cotreated with L. reuteri 2892. Cell treatment with H. pylori HC‐113 promoted cell death, whereas cotreatment with L. reuteri 2892 markedly decreased necrotic and late apoptotic cells. The present study demonstrates that L. reuteri 2892 has potent anti‐H. pylori effects and thus can be considered as an alternative protective agent against inflammatory effects of H. pylori in gastric cells.
- 15 March 2023
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 39 (5) , 1-11
The Anti-Helicobacter pylori effects of Limosilactobacillus reuteri strain 2892 isolated from Camel milk in C57BL/6 mice
Helicobacter pylori infection (H. pylori) is associated with chronic gastritis, peptic ulcers, and gastric cancer. The present study provides information on the protective effects of Limosilactobacillus reuteri strain 2892 (L. reuteri 2892) isolated from camel’s milk against H. pylori-induced gastritis in the stomach tissue of animal models. Animal assays revealed that L. reuteri 2892 pretreatment significantly downregulated the virulence factor cagA gene expression. It upregulated the expression level of tight junction molecules [zona occludens (ZO-1), claudin-4] and suppressed metalloproteinase (MMP)-2 and MMP-9 expressions. L. reuteri 2892 exhibited immunomodulatory effects on cytokine profile, as it reduced the serum concentrations of pro-inflammatory cytokines interleukin (IL)-6, IL-1β, and INF-γ and increased the anti-inflammatory cytokine, IL-10. In addition, L. reuteri 2892 showed anti-oxidative stress activity by regulating the levels of oxidative stress-associated markers [superoxide dismutase (SOD) and malondialdehyde (MDA)]. Our findings suggest that L. reuteri 2892 attenuates H. pylori-induced gastritis.
- 15 March 2023
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 39 (5) , 1-11
The Anti-Helicobacter pylori effects of Limosilactobacillus reuteri strain 2892 isolated from Camel milk in C57BL/6 mice
Helicobacter pylori infection (H. pylori) is associated with chronic gastritis, peptic ulcers, and gastric cancer. The present study provides information on the protective effects of Limosilactobacillus reuteri strain 2892 (L. reuteri 2892) isolated from camel’s milk against H. pylori-induced gastritis in the stomach tissue of animal models. Animal assays revealed that L. reuteri 2892 pretreatment significantly downregulated the virulence factor cagA gene expression. It upregulated the expression level of tight junction molecules [zona occludens (ZO-1), claudin-4] and suppressed metalloproteinase (MMP)-2 and MMP-9 expressions. L. reuteri 2892 exhibited immunomodulatory effects on cytokine profile, as it reduced the serum concentrations of pro-inflammatory cytokines interleukin (IL)-6, IL-1β, and INF-γ and increased the anti-inflammatory cytokine, IL-10. In addition, L. reuteri 2892 showed anti-oxidative stress activity by regulating the levels of oxidative stress-associated markers [superoxide dismutase (SOD) and malondialdehyde (MDA)]. Our findings suggest that L. reuteri 2892 attenuates H. pylori-induced gastritis.
- 23 January 2022
- Published by Wiley in Journal of Food Science
- Vol. 87 (2) , 856-866
Sodium metabisulfite in dried plum and its cytotoxic effects on K‐562 and L‐929 normal cell lines
In the present study, the concentration of sodium metabisulfite (SMB) in dried plums and its toxicity effects on the cell lines of K‐562 (human leukemia cell line) and L‐929 (normal fibroblast cell line) were measured. Samples of dried plums were randomly collected from the shops located in Neyshabur and Mashhad (Iran). SMB residue was measured using iodometric titration and high‐performance liquid chromatography. To analyze the cytotoxicity, the cells were treated with various concentrations of SMB, and cell viability was determined by the MTT and LDH methods. The average concentration of SMB in the samples of dried plums was selected to evaluate the apoptosis/necrosis by flow cytometer. The expression analysis of apoptosis marker genes (BAX, Bcl‐2, and P53) was also assessed. Results indicated that the average concentration of SMB residue in 12 samples of dried plum was 516 ± 285.39 mg/kg. When K‐562 cells were treated with 500 mg/L of SMB, apoptosis increased significantly (p < 0.01). The IC50 of SMB for K‐562 and L‐929 cells after a 48‐h exposure was 200.31 and 257.82 mg/L, respectively. SMB‐treated cells showed that cell viability in both cell lines decreased in a dose‐dependent manner after 72 h (p < 0.01). The percentage of apoptotic but not necrotic cells was 69.49% for K‐562 and 77.32% for L‐929 cells, whereas apoptosis of untreated control cells was 0.17%. Our findings also showed an opposite mRNA expression of Bcl‐2 (anti‐apoptotic marker) and Bax2 (pro‐apoptotic marker) when k‐562 cells were treated with SMB. The results indicated that the concentration of sulfite residue in some dried plums poses a cell toxicity risk for normal cells. Practical Application: The results of current study provide important information concerning the toxicological effects of SMB, and give a warning that it needs to be replaced by natural products for fruit drying processes.
- 23 January 2022
- Published by Wiley in Journal of Food Science
- Vol. 87 (2) , 856-866
Sodium metabisulfite in dried plum and its cytotoxic effects on K‐562 and L‐929 normal cell lines
In the present study, the concentration of sodium metabisulfite (SMB) in dried plums and its toxicity effects on the cell lines of K‐562 (human leukemia cell line) and L‐929 (normal fibroblast cell line) were measured. Samples of dried plums were randomly collected from the shops located in Neyshabur and Mashhad (Iran). SMB residue was measured using iodometric titration and high‐performance liquid chromatography. To analyze the cytotoxicity, the cells were treated with various concentrations of SMB, and cell viability was determined by the MTT and LDH methods. The average concentration of SMB in the samples of dried plums was selected to evaluate the apoptosis/necrosis by flow cytometer. The expression analysis of apoptosis marker genes (BAX, Bcl‐2, and P53) was also assessed. Results indicated that the average concentration of SMB residue in 12 samples of dried plum was 516 ± 285.39 mg/kg. When K‐562 cells were treated with 500 mg/L of SMB, apoptosis increased significantly (p < 0.01). The IC50 of SMB for K‐562 and L‐929 cells after a 48‐h exposure was 200.31 and 257.82 mg/L, respectively. SMB‐treated cells showed that cell viability in both cell lines decreased in a dose‐dependent manner after 72 h (p < 0.01). The percentage of apoptotic but not necrotic cells was 69.49% for K‐562 and 77.32% for L‐929 cells, whereas apoptosis of untreated control cells was 0.17%. Our findings also showed an opposite mRNA expression of Bcl‐2 (anti‐apoptotic marker) and Bax2 (pro‐apoptotic marker) when k‐562 cells were treated with SMB. The results indicated that the concentration of sulfite residue in some dried plums poses a cell toxicity risk for normal cells. Practical Application: The results of current study provide important information concerning the toxicological effects of SMB, and give a warning that it needs to be replaced by natural products for fruit drying processes.
- 15 November 2021
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 37 (4) , 432-440
Metabolic Syndrome and Body Composition Among People Aged 50 Years and Over: Results from The Neyshabur Longitudinal Study on Ageing (NeLSA)
There are few studies regarding body composition and metabolic syndrome (MetS) association in older adults. To evaluate the association between MetS and body composition indices in a large-scale population of subjects with an age of 50 and up. This study was based on the data from Neyshabur Longitudinal Study on Ageing (NeLSA) in a total of 7462 people of Neyshabur city in IRAN. The best cut-off scores and AUC value of body composition variables for having association with likelihood of MetS were determined by using a receiver operating curve analysis. Each unit increase in the Waist/Hip ratio, the odds of having MetS increase 3–6 times (OR: 4.937, 95%CI: 3.930, 6.203 in men; OR: 3.322, 95%CI: 2.259, 4.884 in women). In addition, in the case of BMI (OR: 1.256, 95% Cl: 1.226, 1.286 in men; OR: 1.104, 95% Cl: 1.086, 1.121 in women) and BFM (OR: 1.119, 95% Cl: 1.105, 1.133 in men; OR: 1.050, 95% Cl: 1.041, 1.060 in women), the chance of having MetS increases with increasing these variables. Totally, BMI and BFM showed the best AUC values. The optimal cut-off values for BMI in men was 26.45 and in women was 27.35 and for BFM in men was 23.35 and in women was 26.85. These results suggest that adiposity measures such as BMI and BFM are associated with likelihood of having MetS in subjects with an age of 50 and up, and that avoiding high adiposity is important to prevent MetS incidence.
- 15 November 2021
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 37 (4) , 432-440
Metabolic Syndrome and Body Composition Among People Aged 50 Years and Over: Results from The Neyshabur Longitudinal Study on Ageing (NeLSA)
There are few studies regarding body composition and metabolic syndrome (MetS) association in older adults. To evaluate the association between MetS and body composition indices in a large-scale population of subjects with an age of 50 and up. This study was based on the data from Neyshabur Longitudinal Study on Ageing (NeLSA) in a total of 7462 people of Neyshabur city in IRAN. The best cut-off scores and AUC value of body composition variables for having association with likelihood of MetS were determined by using a receiver operating curve analysis. Each unit increase in the Waist/Hip ratio, the odds of having MetS increase 3–6 times (OR: 4.937, 95%CI: 3.930, 6.203 in men; OR: 3.322, 95%CI: 2.259, 4.884 in women). In addition, in the case of BMI (OR: 1.256, 95% Cl: 1.226, 1.286 in men; OR: 1.104, 95% Cl: 1.086, 1.121 in women) and BFM (OR: 1.119, 95% Cl: 1.105, 1.133 in men; OR: 1.050, 95% Cl: 1.041, 1.060 in women), the chance of having MetS increases with increasing these variables. Totally, BMI and BFM showed the best AUC values. The optimal cut-off values for BMI in men was 26.45 and in women was 27.35 and for BFM in men was 23.35 and in women was 26.85. These results suggest that adiposity measures such as BMI and BFM are associated with likelihood of having MetS in subjects with an age of 50 and up, and that avoiding high adiposity is important to prevent MetS incidence.
- 11 November 2021
- Published by Taylor & Francis in Cancer Investigation
- Vol. 40 (2) , 115-123
Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 Pandemic
Patients with cancer are at significantly greater risk of COVID-19 and its complications than the general population. Since IgG antibodies remain detectable well after infection with the SARS-CoV-2 virus, seroprevalence can be used to estimate the proportion of the cancer population previously infected and potentially immune to SARS-CoV-2. The current study is a multi-center, prospective observational study to assess the seroprevalence of SARS-CoV-2 IgG antibody in a cancer population referred for vaccination between April and June 2021. Of a total of 270 adult patients with cancer accrued, 16% reported a history of COVID-19 more than four weeks previously confirmed by PCR. At the same time, serologic positivity for SARSCoV2 IgG was found in 29% of patients prior to vaccination including nearly 20% of patients without a history of confirmed COVID-19. Seropositivity was significantly greater in females consistent with higher rates in patients with breast cancer and gynecologic cancers. A seroconversion rate of 79.5% was observed in cancer patients with a history of PCR confirmed COVID-19, less than observed in the general population. In multivariable analysis, gender and prior history of COVID-19 were both independently associated with seropositivity prior to vaccination. Follow-up is continuing of this cohort of patients with cancer following vaccination to assess antibody and clinical outcomes.
- 11 November 2021
- Published by Taylor & Francis in Cancer Investigation
- Vol. 40 (2) , 115-123
Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 Pandemic
Patients with cancer are at significantly greater risk of COVID-19 and its complications than the general population. Since IgG antibodies remain detectable well after infection with the SARS-CoV-2 virus, seroprevalence can be used to estimate the proportion of the cancer population previously infected and potentially immune to SARS-CoV-2. The current study is a multi-center, prospective observational study to assess the seroprevalence of SARS-CoV-2 IgG antibody in a cancer population referred for vaccination between April and June 2021. Of a total of 270 adult patients with cancer accrued, 16% reported a history of COVID-19 more than four weeks previously confirmed by PCR. At the same time, serologic positivity for SARSCoV2 IgG was found in 29% of patients prior to vaccination including nearly 20% of patients without a history of confirmed COVID-19. Seropositivity was significantly greater in females consistent with higher rates in patients with breast cancer and gynecologic cancers. A seroconversion rate of 79.5% was observed in cancer patients with a history of PCR confirmed COVID-19, less than observed in the general population. In multivariable analysis, gender and prior history of COVID-19 were both independently associated with seropositivity prior to vaccination. Follow-up is continuing of this cohort of patients with cancer following vaccination to assess antibody and clinical outcomes.
- 26 July 2021
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 21 (14) , 1842-1849
Anticancer Potential of Doxorubicin in Combination with Green-Synthesized Silver Nanoparticle and its Cytotoxicity Effects on Cardio-Myoblast Normal Cells
Background: The use of DOX as an anticancer agent is associated with serious side effects on normal cells especially in cardiovascular tissue. Objective: Here, it is proposed that the combination of a low dose of DOX with AgNPs provides ideal cytotoxicity against cancer cells and decreases side effects on normal human cells. This study evaluates the cytotoxic effects of green-synthetized AgNPs (GS-AgNPs) in combination with DOX in cancerous cells (MCF7) and investigates its influences on cell growth and apoptosis in a normal cell line of the heart (H9c2). Methods: We used coffee extracts, as a reducing and stabilizing agent for the green-synthesis of AgNPs. GSAgNPs were characterized by using various analytical methods. MTT assay was used for cell toxicity analysis in cancerous and normal cells. Moreover, Annexin-V /PI staining and mRNA expression of Bax, Bcl2 and p53 were performed for apoptosis measurement in heart normal cell line. Results: GS-AgNPs showed more biocompatibility for normal cells and higher cytotoxicity for cancerous cells compared to that reported for chemically synthesized nanoparticles. Our results also demonstrated that a selected combination of DOX and AgNPs, 20 μM AgNPs / 0.3 μM DOX, had a suitable cytotoxic effect against cancerous cells with a minimum toxic effect on normal cells. So, no significant alteration was observed in cell migration capacity, apoptosis and gene expression of BAX, Bcl-2 and P53 when H9c2 cells were treated with 20 μM AgNPs / 0.3 μM DOX relative to the non-treated control. Conclusion: Finally, it seems that the combination of GS-AgNPs and DOX could be a potent strategy to combat cancer.
- 26 July 2021
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 21 (14) , 1842-1849
Anticancer Potential of Doxorubicin in Combination with Green-Synthesized Silver Nanoparticle and its Cytotoxicity Effects on Cardio-Myoblast Normal Cells
Background: The use of DOX as an anticancer agent is associated with serious side effects on normal cells especially in cardiovascular tissue. Objective: Here, it is proposed that the combination of a low dose of DOX with AgNPs provides ideal cytotoxicity against cancer cells and decreases side effects on normal human cells. This study evaluates the cytotoxic effects of green-synthetized AgNPs (GS-AgNPs) in combination with DOX in cancerous cells (MCF7) and investigates its influences on cell growth and apoptosis in a normal cell line of the heart (H9c2). Methods: We used coffee extracts, as a reducing and stabilizing agent for the green-synthesis of AgNPs. GSAgNPs were characterized by using various analytical methods. MTT assay was used for cell toxicity analysis in cancerous and normal cells. Moreover, Annexin-V /PI staining and mRNA expression of Bax, Bcl2 and p53 were performed for apoptosis measurement in heart normal cell line. Results: GS-AgNPs showed more biocompatibility for normal cells and higher cytotoxicity for cancerous cells compared to that reported for chemically synthesized nanoparticles. Our results also demonstrated that a selected combination of DOX and AgNPs, 20 μM AgNPs / 0.3 μM DOX, had a suitable cytotoxic effect against cancerous cells with a minimum toxic effect on normal cells. So, no significant alteration was observed in cell migration capacity, apoptosis and gene expression of BAX, Bcl-2 and P53 when H9c2 cells were treated with 20 μM AgNPs / 0.3 μM DOX relative to the non-treated control. Conclusion: Finally, it seems that the combination of GS-AgNPs and DOX could be a potent strategy to combat cancer.
- 30 October 2020
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 68 (6) , 1421-1431
Lactobacillus bulgaricus and Lactobacillus plantarum improve diabetic wound healing through modulating inflammatory factors
Probiotics are nonpathogenic bacterial strains that exert beneficial effects on the host. Previous studies have shown that topical use of some strains of probiotic bacteria have good effects on the healing of cutaneous wounds. In the current study, the wound healing potentials of bacterial probiotics on diabetic cutaneous wounds were evaluated. The effects of probiotics on migration, the viability of fibroblasts, and macrophage proliferation were measured through using wound healing assay, MTT, and BrdU, respectively. In this regard, in vivo diabetic wound healing experiments in Wistar rats following treatment with non‐toxic concentrations of Lactobacillus bulgaricus and Lactobacillus plantarum were conducted. The histopathological and gene expression analyses were performed following removal of wound sites 3, 7, and 14 days post wounding. Results showed that treatment with probiotics accelerated the healing process of diabetic wounds and modulated the inflammatory cells in wound sites during a 14‐day period post‐wounding. The altered mRNA levels of inflammatory cytokines were observed in wound sites following treatment with probiotics. The findings of the current study reveal that L. bulgaricus and L. plantarum could improve the healing of diabetic wounds via regulation of inflammation. This article is protected by copyright. All rights reserved
- 30 October 2020
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 68 (6) , 1421-1431
Lactobacillus bulgaricus and Lactobacillus plantarum improve diabetic wound healing through modulating inflammatory factors
Probiotics are nonpathogenic bacterial strains that exert beneficial effects on the host. Previous studies have shown that topical use of some strains of probiotic bacteria have good effects on the healing of cutaneous wounds. In the current study, the wound healing potentials of bacterial probiotics on diabetic cutaneous wounds were evaluated. The effects of probiotics on migration, the viability of fibroblasts, and macrophage proliferation were measured through using wound healing assay, MTT, and BrdU, respectively. In this regard, in vivo diabetic wound healing experiments in Wistar rats following treatment with non‐toxic concentrations of Lactobacillus bulgaricus and Lactobacillus plantarum were conducted. The histopathological and gene expression analyses were performed following removal of wound sites 3, 7, and 14 days post wounding. Results showed that treatment with probiotics accelerated the healing process of diabetic wounds and modulated the inflammatory cells in wound sites during a 14‐day period post‐wounding. The altered mRNA levels of inflammatory cytokines were observed in wound sites following treatment with probiotics. The findings of the current study reveal that L. bulgaricus and L. plantarum could improve the healing of diabetic wounds via regulation of inflammation. This article is protected by copyright. All rights reserved
- 10 March 2020
- Published by Hindawi Limited in Journal of Food Biochemistry
- Vol. 44 (5) , e13177
Dietary fats promote inflammation in Wistar rats as well as induce proliferation, invasion of SKOV3 ovarian cancer cells
The role of high fat diet (HFD) in ovarian cancer and its underlying mechanisms are poorly known. In current investigation, we investigated inflammatory and oncogenic effect of dietary fats in female Wistar rats and ovarian cancer cell line (SKOV3). The ELISA kits were used for adipokines and inflammatory factors analyses in sera collected from rats fed with high fat diet (SR‐HFD). Cell growth, proliferation, apoptosis, migration, and invasion were measured in SKOV3 cells treated with the SR‐HFD and FA mix. IL6, IL1β, TNFα, NF‐kβ, and p53 expression were measured in cells incubated with the mentioned treatments. Leptin and inflammatory factors increased, while adiponectin decreased in SR‐HFD. Moreover, FA mix significantly induced proliferation, migration, and invasion, promoted the expression of inflammatory factors and NF‐κB and inhibited apoptosis markers in SKOV3 cells. Taken together, our findings revealed that diet might be a crucial factor in ovarian cancer progression through altering the inflammatory factors. Practical applications The HFD‐mediated obesity promotes cancer progression in various tissues. This study highlights the progression of inflammation in female Wistar rats and the growth of ovarian cancer cells by dietary fats. Thus, dietary factors can be considered as key factors for the prevention of ovarian cancer.
- 10 March 2020
- Published by Hindawi Limited in Journal of Food Biochemistry
- Vol. 44 (5) , e13177
Dietary fats promote inflammation in Wistar rats as well as induce proliferation, invasion of SKOV3 ovarian cancer cells
The role of high fat diet (HFD) in ovarian cancer and its underlying mechanisms are poorly known. In current investigation, we investigated inflammatory and oncogenic effect of dietary fats in female Wistar rats and ovarian cancer cell line (SKOV3). The ELISA kits were used for adipokines and inflammatory factors analyses in sera collected from rats fed with high fat diet (SR‐HFD). Cell growth, proliferation, apoptosis, migration, and invasion were measured in SKOV3 cells treated with the SR‐HFD and FA mix. IL6, IL1β, TNFα, NF‐kβ, and p53 expression were measured in cells incubated with the mentioned treatments. Leptin and inflammatory factors increased, while adiponectin decreased in SR‐HFD. Moreover, FA mix significantly induced proliferation, migration, and invasion, promoted the expression of inflammatory factors and NF‐κB and inhibited apoptosis markers in SKOV3 cells. Taken together, our findings revealed that diet might be a crucial factor in ovarian cancer progression through altering the inflammatory factors. Practical applications The HFD‐mediated obesity promotes cancer progression in various tissues. This study highlights the progression of inflammation in female Wistar rats and the growth of ovarian cancer cells by dietary fats. Thus, dietary factors can be considered as key factors for the prevention of ovarian cancer.